E645-2656 Screening compound: 8-chloro-6-[4-(4-methylpiperazino)-4-oxobutyl]pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one

E645-2656 Screening compound: 8-chloro-6-[4-(4-methylpiperazino)-4-oxobutyl]pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one
E645-2656 Screening compound: 8-chloro-6-[4-(4-methylpiperazino)-4-oxobutyl]pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E645-2656
8-chloro-6-[4-(4-methylpiperazino)-4-oxobutyl]pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E645-2656

Molecular Formula

C21H23ClN4O3 (C21 H23 ClN4 O3)

Compound Name

8-chloro-6-[4-(4-methylpiperazino)-4-oxobutyl]pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one

IUPAC name

13-chloro-10-[4-(4-methylpiperazin-1-yl)-4-oxobutyl]-2-oxa-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-9-one

SMILES

CN(CC1)CCN1C(CCCN(c(cc(cc1)Cl)c1Oc1c2cccn1)C2=O)=O

InChI

InChI=1S/C21H23ClN4O3/c1-24-10-12-25(13-11-24)19(27)5-3-9-26-17-14-15(22)6-7-18(17)29-20-16(21(26)28)4-2-8-23-20/h2,4,6-8,14H,3,5,9-13H2,1H3

InChI Key

ACXSHCOVQRQUFD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14907808

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.89

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.840

Distribution Coefficient, logD

1.593

Water Solubility, LogSw

-2.94

Polar Surface Area

52.380

Acid Dissociation Constant (pKa)

23.66

Base Dissociation Constant (pKb)

7.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

E645-2656 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E645-2656 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E645-2656?
Check Price and Availability of E645-2656, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E645-2656 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E645-2656
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E645-2656
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E645-2656 available by request